Document is current

Any future updates will be listed below

Effectiveness and safety of vonoprazan-based regimens compared with those of proton pump inhibitor (PPI)–based regimens as first-line agents for Helicobacter pylori: a meta-analysis of randomized clinical trials

Crossref DOI link: https://doi.org/10.1007/s00228-022-03430-y

Published Online: 2022-12-17

Published Print: 2023-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark